Laurion Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-96,300
Closed -$11.9M 546
2023
Q4
$11.9M Buy
96,300
+65,000
+208% +$6.64M 0.1% 173
2023
Q3
$2.92M Buy
+31,300
New +$3.53M 0.02% 314
2023
Q2
Sell
-75,000
Closed -$8.71M 624
2023
Q1
$8.71M Buy
+75,000
New +$8.4M 0.06% 209
2020
Q4
Sell
-123,600
Closed -$12.7M 710
2020
Q3
$12.7M Buy
+123,600
New +$12.9M 0.15% 143

Other funds holding DXCM

Laurion Capital Management's DXCM Position: Q4 2023 in Review

Laurion Capital Management sold out of DexCom (DXCM) in Q4 2023, closing a stake of 16,954 shares — an estimated $1.73M sold.

Laurion Capital Management first reported a position in DXCM in Q2 2015 and held it in 9 quarters. The position peaked at $5.39M in Q2 2015. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Laurion Capital Management reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Laurion Capital Management sold 16,954 DexCom shares in Q4 2023, an estimated $1.73M.
  • Laurion Capital Management first reported a position in DexCom in Q2 2015 and held it in 9 quarters.
  • Laurion Capital Management's DexCom position peaked at $5.39M in Q2 2015.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Laurion Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.